Assetmark »

Agios Pharmaceuticals shares owned by Assetmark

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Assetmark

Quarter filed Position value Share count Share price at filing
2024-09-30 $25k 555 44.43
2024-06-30 $24k 555 43.12
2024-03-31 $16k 555 29.24

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Ishares Tr Core S&p500 Etf (IVV)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Core Msci Emkt (IEMG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)

View all positions for Assetmark

Top funds holding Agios Pharmaceuticals

BlackRock
Bellevue Group
T. Rowe Price Associates
Erste Asset Management GmbH
Jpmorgan Chase & Co
Dimensional Fund Advisors
Geode Capital Management
Marshall Wace
BVF
Frazier Life Sciences Management
Bnp Paribas Investment Partners
Arrowpoint Asset Management
Fisher Investments
Vestal Point Capital
Deutsche Bank Aktiengesellschaft

View all funds holding Agios Pharmaceuticals